Cancer, Obesity/Overweight and Insomnia Study
Status: | Recruiting |
---|---|
Conditions: | Breast Cancer, Cancer, Insomnia Sleep Studies, Obesity Weight Loss, Obesity Weight Loss |
Therapuetic Areas: | Endocrinology, Oncology, Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/20/2018 |
Start Date: | June 12, 2018 |
End Date: | June 1, 2020 |
Contact: | Alexandra Kearson |
Email: | akearso1@jhmi.edu |
Phone: | 410-550-9056 |
The Effects of Treating Insomnia Prior to a Weight Loss Intervention in Women With Early Stage Breast Cancer
This is a randomized pilot study to better understand the relationships among insomnia,
weight loss, and breast cancer. This study will assess the effectiveness of a sleep
intervention prior to a web- and phone-based weight loss program.
weight loss, and breast cancer. This study will assess the effectiveness of a sleep
intervention prior to a web- and phone-based weight loss program.
Participants are women with a diagnosis of early stage breast cancer (ESBC), a BMI ≥25, and
insomnia. A total of 30 participants will be randomized to either cognitive behavioral
therapy for insomnia and behavioral weight loss (CBT-I+BWL) or a sleep education program and
behavioral weight loss (EDU+BWL). Measures will be collected at baseline, 8 weeks (after the
CBT-I or EDU program) and at 3 and 6 months after starting BWL. The primary outcome will be %
total weight loss. Additionally, eating behaviors, physical activity, and sleep parameters
will be carefully assessed.
The sleep intervention phase of the study includes 6 sessions over 8 weeks (2 in-person,
followed by 4 phone or videoconferencing sessions), and the BWL intervention includes 15
sessions over 6 months (1 in-person, 14 by phone or videoconference). Participants will be
given physical activity trackers and will use a dietary app to record their food intake.
There are 4 in-person assessment visits (baseline/randomization, 8-week follow up, 3-month
follow up, 6-month follow up). These assessment visits are coordinated with in-person sleep
and weight loss intervention visits. Some of the measures that will be recorded throughout
the study include: height, weight, anthropometric measures (waist/hip measurements), sleep
diaries, and self-report measures.
insomnia. A total of 30 participants will be randomized to either cognitive behavioral
therapy for insomnia and behavioral weight loss (CBT-I+BWL) or a sleep education program and
behavioral weight loss (EDU+BWL). Measures will be collected at baseline, 8 weeks (after the
CBT-I or EDU program) and at 3 and 6 months after starting BWL. The primary outcome will be %
total weight loss. Additionally, eating behaviors, physical activity, and sleep parameters
will be carefully assessed.
The sleep intervention phase of the study includes 6 sessions over 8 weeks (2 in-person,
followed by 4 phone or videoconferencing sessions), and the BWL intervention includes 15
sessions over 6 months (1 in-person, 14 by phone or videoconference). Participants will be
given physical activity trackers and will use a dietary app to record their food intake.
There are 4 in-person assessment visits (baseline/randomization, 8-week follow up, 3-month
follow up, 6-month follow up). These assessment visits are coordinated with in-person sleep
and weight loss intervention visits. Some of the measures that will be recorded throughout
the study include: height, weight, anthropometric measures (waist/hip measurements), sleep
diaries, and self-report measures.
Inclusion Criteria:
- Female
- 18 years of age or older
- Histologically-confirmed ductal carcinoma in-situ (DCIS) or stage I-III invasive
carcinoma of the breast
- Current BMI ≥ 25 kg/m2 and weight ≤ 400 lbs
- Willing to lose 10% of body weight
- Diagnosed with current breast cancer >3 and <60 months from planned baseline visit
date
- Completed local therapy (i.e. surgery and radiation therapy) and any planned
preoperative or adjuvant chemotherapy within >3 prior to enrollment
- Diagnosed with insomnia or reports sleep problems
- Has daily access to the internet and/or smartphone
Exclusion Criteria:
- Serious/uncontrolled condition likely to hinder accurate measurement of weight or
sleep, such as bipolar I, seizure disorders, autoimmune disease, etc., or a medical
condition that makes physical activity unsafe
- Current use of weight loss medications or sleeping aids
- Current enrollment in a sleep or weight loss program
- Sleep disorder other than insomnia
- Plan to become pregnant within next 12 months, or lactating
We found this trial at
1
site
Baltimore, Maryland 21224
Principal Investigator: Janelle Coughlin, Ph.D.
Phone: 410-550-9056
Click here to add this to my saved trials